SCHEMBL4539683

SCHEMBL4539683

C[C@](F)(C(=O)O)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.62
KIF11 P52732 1/20 0.54
PTPN5 P54829 1/20 0.53
PTPN1 P18031 1/20 0.46
MAPT P10636 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
BACE1 P56817 2/20 0.44
KMT2A Q03164 1/20 0.44
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
CTDSP1 Q9GZU7 1/20 0.42
RXRA P19793 1/20 0.42
RXRB P28702 1/20 0.42
APP P05067 1/20 0.41
PTGS2 P35354 1/20 0.41
FFAR1 O14842 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4167158 1.00 CYP2C9 (0.62) CYP2C9KIF11PTPN5PTPN1MAPT
SCHEMBL1063470 1.00 CYP2C9 (0.62) CYP2C9KIF11PTPN5PTPN1MAPT
SCHEMBL4517127 0.87 MAPT (0.50) CYP2C9PTPN1MAPTKMT2A
SCHEMBL4517619 0.87 MAPT (0.50) CYP2C9PTPN1MAPTKMT2A
SCHEMBL4517129 0.87 MAPT (0.50) CYP2C9PTPN1MAPTKMT2A
Water SCHEMBL4920744 0.82 CYP2C9 (0.50) CYP2C9KIF11PTPN5PTPN1MAPT
SCHEMBL31619475 0.81 CES2 (0.52) KIF11PTPN1NPC1RAB9AAPP
SCHEMBL27608748 0.79 PDK1 (0.51) CYP2C9SMN1; SMN2KMT2ANPC1RAB9A
SCHEMBL1679690 0.79 CYP2C9 (0.61) CYP2C9KIF11PTPN5MAPTSMN1; SMN2
SCHEMBL3087883 0.79 CYP2C9 (0.61) CYP2C9KIF11PTPN5MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2468270-A1 (R)-2-(3-fluoro-4-phenylphenyl)propionic acid for use in the treatment of skin diseases GALENpharma GmbH (DE) 2012-06-27 EP disclosed
WO-2009034457-A1 ORGANIC COMPOUNDS USEFUL FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES, USES AND METHODS FOR THE PREPARATION THEREOF ALMA MATER STUDIORUM - UNIVERSITA' DI BOLOGNA (IT) 2009-03-19 WO disclosed